{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:35:11Z","timestamp":1787319311163,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004492","name":"National Youth Foundation of China","doi-asserted-by":"publisher","award":["21MC1930500"],"award-info":[{"award-number":["21MC1930500"]}],"id":[{"id":"10.13039\/501100004492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People&apos;s Republic of China","doi-asserted-by":"publisher","award":["ZYYCXTD-C-202208"],"award-info":[{"award-number":["ZYYCXTD-C-202208"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.joim.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T19:18:40Z","timestamp":1745349520000},"page":"320-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Morin inhibits ubiquitination degradation of BCL-2 associated agonist of cell death and synergizes with BCL-2 inhibitor in gastric cancer cells"],"prefix":"10.1016","volume":"23","author":[{"given":"Yi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-qi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-ming","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-han","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-meng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni-da","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-geng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-fu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-guang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.joim.2025.04.006_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.joim.2025.04.006_b0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"10251","key":"10.1016\/j.joim.2025.04.006_b0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.joim.2025.04.006_b0020","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"10.1016\/j.joim.2025.04.006_b0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/annonc\/mdw040","article-title":"Molecular classification of gastric cancer","volume":"27","author":"Chia","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.joim.2025.04.006_b0030","first-page":"107","article-title":"Blueprint for cancer research: critical gaps and opportunities","volume":"71","author":"Elmore","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.joim.2025.04.006_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156003","article-title":"Mechanisms of traditional Chinese medicine in the treatment and prevention of gastric cancer","volume":"135","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.joim.2025.04.006_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100881","article-title":"Paclitaxel resistance related to nuclear envelope structural sturdiness","volume":"65","author":"Smith","year":"2022","journal-title":"Drug Resist Updat"},{"issue":"12","key":"10.1016\/j.joim.2025.04.006_b0045","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/annonc\/mdf337","article-title":"Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity","volume":"13","author":"Xu","year":"2002","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.joim.2025.04.006_b0050","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/nu12030721","article-title":"Prunellae Spica extract suppresses teratoma formation of pluripotent stem cells through p53-mediated apoptosis","volume":"12","author":"Kim","year":"2020","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.joim.2025.04.006_b0055","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/molecules29081843","article-title":"Anti-tumor effects and toxicity reduction mechanisms of Prunella vulgaris: a comprehensive review","volume":"29","author":"Ning","year":"2024","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.joim.2025.04.006_b0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2174\/1386207323999200730210536","article-title":"Uncovering active ingredients and mechanisms of Spica Prunellae in the treatment of colon adenocarcinoma: a study based on network pharmacology and bioinformatics","volume":"24","author":"Lei","year":"2021","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1016\/j.joim.2025.04.006_b0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.foodchem.2016.02.047","article-title":"Phytochemistry and pharmacological activities of the genus Prunella","volume":"204","author":"Bai","year":"2016","journal-title":"Food Chem"},{"key":"10.1016\/j.joim.2025.04.006_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111511","article-title":"Morin hydrate: a comprehensive review on novel natural dietary bioactive compound with versatile biological and pharmacological potential","volume":"138","author":"Rajput","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.joim.2025.04.006_b0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3892\/or.2021.8077","article-title":"Evaluation of the antimetastatic and anticancer activities of morin in HER2\u2011overexpressing breast cancer SK\u2011BR\u20113 cells","volume":"46","author":"Lee","year":"2021","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.joim.2025.04.006_b0080","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s43440-021-00272-w","article-title":"Cell cycle arrest-mediated cell death by morin in MDA-MB-231 triple-negative breast cancer cells","volume":"73","author":"Maharjan","year":"2021","journal-title":"Pharmacol Rep"},{"issue":"6","key":"10.1016\/j.joim.2025.04.006_b0085","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00404-018-4912-4","article-title":"Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin","volume":"298","author":"Bieg","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.joim.2025.04.006_b0090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12272-019-01158-5","article-title":"Flavonoid morin inhibits proliferation and induces apoptosis of melanoma cells by regulating reactive oxygen species, Sp1 and Mcl-1","volume":"42","author":"Lee","year":"2019","journal-title":"Arch Pharm Res"},{"issue":"5","key":"10.1016\/j.joim.2025.04.006_b0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.joim.2025.04.006_b0100","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00210-020-02018-6","article-title":"Apatinib regulates the growth of gastric cancer cells by modulating apoptosis and autophagy","volume":"394","author":"Liu","year":"2021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.joim.2025.04.006_b0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<14::AID-CNCR4>3.0.CO;2-N","article-title":"Paclitaxel-induced apoptosis in human gastric carcinoma cell lines","volume":"77","author":"Chang","year":"1996","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.joim.2025.04.006_b0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res"},{"issue":"7","key":"10.1016\/j.joim.2025.04.006_b0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.joim.2025.04.006_b0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drup.2009.02.002","article-title":"Targeting apoptosis as an approach for gastrointestinal cancer therapy","volume":"12","author":"Qiao","year":"2009","journal-title":"Drug Resist Updat"},{"issue":"2","key":"10.1016\/j.joim.2025.04.006_b0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0092-8674(95)90411-5","article-title":"BAD, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death","volume":"80","author":"Yang","year":"1995","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.joim.2025.04.006_b0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13073-022-01115-w","article-title":"Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment","volume":"14","author":"Lee","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.joim.2025.04.006_b0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.canlet.2017.11.017","article-title":"BAD phosphorylation as a target of inhibition in oncology","volume":"415","author":"Bui","year":"2018","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.joim.2025.04.006_b0140","doi-asserted-by":"crossref","first-page":"191619","DOI":"10.1158\/0008-5472.CAN-07-3195","article-title":"Enzastaurin, a protein kinase C\u03b2 inhibitor, suppresses signaling through the ribosomal S6 kinase and Bad pathways and induces apoptosis in human gastric cancer cells","volume":"68","author":"Lee","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.joim.2025.04.006_b0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","article-title":"Proteasomal and autophagic degradation systems","volume":"86","author":"Dikic","year":"2017","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"10.1016\/j.joim.2025.04.006_b0150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res"},{"issue":"3","key":"10.1016\/j.joim.2025.04.006_b0155","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1128\/IAI.73.3.1399-1403.2005","article-title":"Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with Chlamydia trachomatis","volume":"73","author":"Ying","year":"2005","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.joim.2025.04.006_b0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1756-9966-29-107","article-title":"Expression of the apoptosis-related genes BCL-2 and BAD in human breast carcinoma and their associated relationship with chemosensitivity","volume":"29","author":"Yu","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.joim.2025.04.006_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5382263","article-title":"Daurisoline inhibits ESCC by inducing G1 cell cycle arrest and activating ER stress to trigger Noxa-dependent intrinsic and CHOP-DR5-dependent extrinsic apoptosis via p-eIF2\u03b1-ATF4 axis","volume":"2022","author":"Yuan","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.joim.2025.04.006_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102435","article-title":"Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation","volume":"56","author":"Li","year":"2022","journal-title":"Redox Biol"},{"issue":"6","key":"10.1016\/j.joim.2025.04.006_b0175","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s12975-021-00888-3","article-title":"The key regulator of necroptosis, RIP1 kinase, contributes to the formation of astrogliosis and glial scar in ischemic stroke","volume":"12","author":"Zhu","year":"2021","journal-title":"Transl Stroke Res"},{"issue":"7950","key":"10.1016\/j.joim.2025.04.006_b0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41586-023-05704-6","article-title":"Targeting TBK1 to overcome resistance to cancer immunotherapy","volume":"615","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.joim.2025.04.006_b0185","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1038\/s41418-020-00724-5","article-title":"Tumor-associated antigen prame targets tumor suppressor p14\/ARF for degradation as the receptor protein of CRL2Prame complex","volume":"28","author":"Zhang","year":"2021","journal-title":"Cell Death Differ"},{"issue":"22","key":"10.1016\/j.joim.2025.04.006_b0190","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1038\/s41388-018-0180-9","article-title":"KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells","volume":"37","author":"Zhu","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.joim.2025.04.006_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106704","article-title":"m6A methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis","volume":"189","author":"Chen","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.joim.2025.04.006_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154866","article-title":"Morin exhibits a neuroprotective effect in MPTP-induced Parkinson\u2019s disease model via TFEB\/AMPK-mediated mitophagy","volume":"116","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.joim.2025.04.006_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112846","article-title":"Morin alleviates DSS-induced ulcerative colitis in mice via inhibition of inflammation and modulation of intestinal microbiota","volume":"140","author":"Qiu","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"7042","key":"10.1016\/j.joim.2025.04.006_b0210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.joim.2025.04.006_b0215","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3892\/ijo.2015.2967","article-title":"The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells","volume":"46","author":"Hyun","year":"2015","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.joim.2025.04.006_b0220","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/annonc\/mdf191","article-title":"Inhibition of Bcl-2 as cancer therapy","volume":"13","author":"Ciardiello","year":"2002","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.joim.2025.04.006_b0225","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","article-title":"The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells","volume":"9","author":"Nechiporuk","year":"2019","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.joim.2025.04.006_b0230","doi-asserted-by":"crossref","first-page":"8728","DOI":"10.1016\/j.ccell.2020.10.010","article-title":"Reduced mitochondrial apoptotic priming drives resistance to BH3 mimetics in acute myeloid leukemia","volume":"38","author":"Bhatt","year":"2020","journal-title":"Cancer Cell"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496425000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496425000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:05:53Z","timestamp":1762599953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496425000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2095496425000500"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2025.04.006","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morin inhibits ubiquitination degradation of BCL-2 associated agonist of cell death and synergizes with BCL-2 inhibitor in gastric cancer cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}